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DEVELOPMENT OF TYPE 2 DIABETES MELLITUS 
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CONCLUSIONS
IUGR leads to a reprogramming process that persists throughout life and to a progressive development of a T2DM phenotype. Mitochondrial dysfunction plays an important role in β-
cells because of their vulnerability to ROS. On the other hand, the epigenetic silencing of Pdx1 suggests therapeutic agents for the prevention of common diseases with late-onset
phenotypes.
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 Have a high oxidative 
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 Decrease gene expression
 β-cell death
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INTRODUCTION
Intrauterine growth retardation (IUGR) is a common complication of pregnancy
characterized by decreased body weight and body mass of foetus, related to other foetus at
same gestational weeks. Many studies correlate IUGR with the later development of adult
diseases (e.g. pregnant women exposed to the Dutch Hunger Winter of 1944-1945 delivered
infants with lower birth weight. By age 50, these offspring has impaired glucose tolerance).
These studies led to the formulation of the ‘developmental plasticity theory’ which consists
in the ability of the organism to change structure and function in response to environmental
signals. IUGR displays a significant risk for:
Developmental plasticity theory: in utero epigenetic programming.
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PANCREATIC DUODENAL HOMEOBOX 1
(PDX1)
A transcription factor that plays an essential role
in:
 Early pancreas development
 β-cell differentiation
 Maintenance of mature β-cell function
Pdx1 is a gene susceptible to increased
epigenetic modifications (especially DNA
methylation).
Pdx1 role in early pancreas development and β-cell 
differentiation
Epigenetic silencing process in Pdx1 gene
 Obesity
 Hypertension
 Dyslipidaemia
 Insulin resistance
 Type 2 diabetes mellitus
EPIGENETIC MODIFICATIONS IN KEY GENES OF T2DM DEVELOPMENT
T2DM adulthood
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 β-cell dysfunction
 Impair insulin secretion
Histone deacetylation (loss USF-1 binding + repressor complex 
recruitment) 
DNA methyltransferase 1 (Dnmt1) recruitment 
↓H3K4 trimethylation / ↑H3K9 dimethylation
DNA methyltransferase 3a (Dnmt3a) recruitment
DNA methylation CpG islands
Permanent repression of Pdx1
EPIGENETIC SILENCING OF PDX1
MITOCHONDRIAL 
DYSFUNCTION
Molecular process in mitochondria
TYPE 2 DIABETES MELLITUS
A chronic metabolic disease caused by an impaired sensitivity to insulin of insulin-responsive tissues coupled
with insufficient β-cell compensation, characterized by hyperglycaemia and altered lipid metabolism. Therefore,
the pancreas is a key player for the development of T2DM.
